B Heppy

Insight on hepatitis B curative drug development with Dr. Mike Sofia

November 04, 2022 Hepatitis B Foundation
B Heppy
Insight on hepatitis B curative drug development with Dr. Mike Sofia
Show Notes

On this episode B Heppy we sit down with Dr. Mike Sofia, Co-founder and Chief Scientific Officer at Arbutus Biopharma to talk about his company's work on hepatitis B curative therapies. Listen and learn more about the pre-clinical process. 

Resources:
Arbutus Biopharma
Drug Watch
Clinical Trial Finder 

Support the show

Our website: www.hepb.org
Support B Heppy!
Social Media: Instagram - Twitter - Facebook